IMARC Group's report titled "Anastomosis Devices Market Report by Type (Surgical Staplers, Surgical Sutures, Automated Suturing Devices, Surgical Sealants and Adhesives), Application (Gastrointestinal Surgeries, Cardiovascular and Thoracic Surgeries, and Others), End User (Hospitals, Ambulatory Surgical Centers and Clinics, and Others), and Region 2024-2032". The global anastomosis devices market size reached US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.0 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/anastomosis-devices-market/requestsample

Factors Affecting the Growth of the Anastomosis Devices Industry:

• Increasing Surgical Procedures:

The increasing number of surgical procedures across various medical specialties is driving the demand for anastomosis devices. Besides this, the global population is aging, leading to a higher incidence of age-related health issues that require surgical treatment. Additionally, advancements in medical technology and techniques are making surgeries safer and more accessible, encouraging more patients to undergo surgical procedures. Furthermore, minimally invasive (MI) surgery techniques are becoming popular, and anastomosis devices are vital in enabling precise connections in these procedures. These devices facilitate MI procedures, leading to quicker recovery times, reduced hospital stays, and lower post-operative complications.

• Advancements in Anastomosis Technology:

The continuous evolution of anastomosis technology is propelling the market growth. Medical device manufacturers are consistently investing in research and development (R&D) to create innovative anastomosis devices. These advancements aim to improve the precision and efficiency of creating connections between blood vessels or digestive tract segments during surgeries. Modern anastomosis devices incorporate features like stapling mechanisms, robotic assistance, and real-time imaging, which enhance the accuracy and safety of surgical procedures. Surgeons can achieve more predictable outcomes with reduced risks of complications, promoting the adoption of these devices.

• Aging Population and Chronic Diseases:

The aging population and the increasing prevalence of chronic diseases are significant factors driving the demand for anastomosis devices. As the global population ages, there is a corresponding rise in age-related health conditions that necessitate surgical interventions. These conditions include cardiovascular diseases, colorectal disorders, and cancer, among others. Anastomosis devices play a critical role in addressing these health challenges by facilitating the reconnection of blood vessels, intestines, or other anatomical structures. As chronic diseases become more widespread, the demand for surgical treatments and anastomosis devices continues to grow.

Leading Companies Operating in the Global Anastomosis Devices Industry:

• Artivion Inc.
• B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG)
• Becton
• Dickinson and Company
• Getinge AB
• Intuitive Surgical Inc.
• Johnson & Johnson
• Meril Life Sciences Pvt. Ltd.
• Peters Surgical
• Synovis Micro Companies Alliance Inc. (Baxter International Inc.)

Anastomosis Devices Market Report Segmentation:

By Type:

• Surgical Staplers
  • Manual
  • Powered
• Surgical Sutures
  • Absorbable Sutures
    • Synthetic Sutures
    • Natural Sutures
  • Non-absorbable Sutures
    • Polypropylene
    • Nylon
    • Stainless Steel
    • Others
• Automated Suturing Devices
  • Disposable
  • Reusable
• Surgical Sealants and Adhesives
  • Natural/Biological
    • Fibrin-based
    • Collagen-based
    • Albumin-based
  • Synthetic and Semisynthetic
    • PEG Hydrogel-based
    • Cyanoacrylate-based
    • Others

Surgical staplers represent the largest segment, as they can be used effortlessly.

By Application:

• Gastrointestinal Surgeries
• Cardiovascular and Thoracic Surgeries
• Others

Cardiovascular and thoracic surgeries account for the majority of the market share due to their reliance on anastomosis devices to create connections between healthy blood vessels.

By End Use:

• Hospitals
• Ambulatory Surgical Centers and Clinics
• Others

Hospitals exhibit a clear dominance in the market. They require anastomosis devices for conducting MI surgeries (MIS) to provide quicker recovery times.

Regional Insights:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

North America's dominance in the anastomosis devices market is attributed to increasing investments in improving the medical infrastructure.

Global Anastomosis Devices Market Trends:

The expansion and improvement of healthcare infrastructure have played a pivotal role in driving the demand for anastomosis devices. As countries invest in upgrading their medical facilities and surgical capabilities, there is a greater need for advanced medical equipment, including anastomosis devices. This trend is particularly evident in regions experiencing rapid economic growth and urbanization, where healthcare facilities are being modernized to meet the rising healthcare demands of their populations. The prevalence of lifestyle-related diseases, such as obesity and diabetes, is rising around the world. These conditions often necessitate surgical interventions, such as gastric bypass surgeries and vascular procedures, where anastomosis devices are indispensable. The growing awareness of the health risks associated with sedentary lifestyles and poor dietary habits is prompting individuals to seek medical interventions, further fueling the demand for these devices.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145